Partnering for Philanthropy Conference Launched to Unite Innovative Non-profit Research Organizations with Philanthropists and Industry
According to FasterCures, non-profit foundations are ideally positioned tomake relatively high-risk, high-reward investments that could significantlymove a field of research forward. However, the lack of independent, reliabledata about non-profit disease research opportunities is a major barrier toencouraging significant support for such research and to improving theefficiency and productivity of the philanthropy.
The new Partnering for Philanthropy meeting is designed to leverage andexpand the critical role philanthropic funders can play in stimulatingresearch in under-resourced disease areas, and help bridge the widening"valley of death" in research funding between basic discovery and later-stageresearch.
"We believe there is a strong need to bridge the information gapseparating philanthropy and non-profit medical research organizations if weare to accelerate medical solutions," said Greg Simon, President, FasterCures."This meeting will help narrow this gap by infusing the medical researchphilanthropic process with the right information, the appropriate tools, andthe networks to connect diverse groups."
"A well-recognized translational research gap also exists in the drugdevelopment path between the end of academic research funding and thebeginning of typical biopharmaceutical drug development programs," stated RickFranklin, Chairman of DMS Data Systems. "The new Partnering for Philanthropyconference will bridge this gap and provide an opportunity for non-profitmedical research and patient advocacy organizations to pinpoint vital fundingand development commitments from pharmaceutical and biotech companiesalongside philanthropists engaged in funding medical innovation."
Partnering for Philanthropy will offer researchers and potentialdevelopers and/or funding sources access to a proprietary online partneringsystem that will provide profiles of organizations, provide informationresources and allow users to arrange meetings in real-time. Panel discussionsat the conference will also focus directly on new developments in venturephilanthropy and translational research. Preliminary program components willinclude:
"This event is modeled after the partnering meetings developed by theBiotechnology Industry Organization (BIO) and EBD Group which have changed theway pharmaceutical and biotechnology companies exchange information and dobusiness," said Sara Jane Demy of Demy-Colton Life Science Advisors. "Webelieve the Partnering for Philanthropy conference will create extraordinaryand much-needed opportunities to accelerate new drug development acrossnumerous therapeutic fields."
About DMS Data Systems: DMS Data Systems provides business information tothe medical industry in the form of online databases. Its products include theNewsAnalyzer, a database of all press releases issued by all medical andpharmaceutical companies; the IndustryAnalyzer, a database of 6000 medical andpharmaceutical company profiles; and Clinical Trials Plus, a databasecontaining all registered clinical trials.
About Demy-Colton Life Science Advisors: Demy-Colton is a consultingcompany focused exclusively on facilitating the growth of the life sciencesindustry. Sara Demy, the principal of Demy-Colton and previously theBiotechnology Industry Organization's Vice President of Business Developmentand Investor Relations, is a leader at designing and developing high-valueadded programs and services
You May Also Like